BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26822263)

  • 1. Examining the Role of Sphingosine Kinase-2 in the Regulation of Endothelial Cell Barrier Integrity.
    Dimasi DP; Pitson SM; Bonder CS
    Microcirculation; 2016 Apr; 23(3):248-65. PubMed ID: 26822263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent.
    Sun WY; Abeynaike LD; Escarbe S; Smith CD; Pitson SM; Hickey MJ; Bonder CS
    Am J Pathol; 2012 Apr; 180(4):1740-50. PubMed ID: 22322303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1.
    Li X; Stankovic M; Bonder CS; Hahn CN; Parsons M; Pitson SM; Xia P; Proia RL; Vadas MA; Gamble JR
    Blood; 2008 Apr; 111(7):3489-97. PubMed ID: 18199826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
    Yan G; Chen S; You B; Sun J
    Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.
    Xun C; Chen MB; Qi L; Tie-Ning Z; Peng X; Ning L; Zhi-Xiao C; Li-Wei W
    J Exp Clin Cancer Res; 2015 Sep; 34(1):94. PubMed ID: 26337959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.
    Chumanevich AA; Poudyal D; Cui X; Davis T; Wood PA; Smith CD; Hofseth LJ
    Carcinogenesis; 2010 Oct; 31(10):1787-93. PubMed ID: 20688834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis.
    Snider AJ; Ruiz P; Obeid LM; Oates JC
    PLoS One; 2013; 8(1):e53521. PubMed ID: 23301082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
    Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR
    Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
    Antoon JW; White MD; Slaughter EM; Driver JL; Khalili HS; Elliott S; Smith CD; Burow ME; Beckman BS
    Cancer Biol Ther; 2011 Apr; 11(7):678-89. PubMed ID: 21307639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate has dual functions in the regulation of endothelial cell permeability and Ca2+ metabolism.
    Itagaki K; Yun JK; Hengst JA; Yatani A; Hauser CJ; Spolarics Z; Deitch EA
    J Pharmacol Exp Ther; 2007 Oct; 323(1):186-91. PubMed ID: 17626797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth.
    Zhou J; Chen J; Yu H
    Biochem Biophys Res Commun; 2018 Mar; 497(2):535-542. PubMed ID: 29428730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase inhibition alleviates endothelial permeability induced by thrombin and activated neutrophils.
    Itagaki K; Zhang Q; Hauser CJ
    Shock; 2010 Apr; 33(4):381-6. PubMed ID: 19851125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
    Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
    Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.
    Antoon JW; White MD; Meacham WD; Slaughter EM; Muir SE; Elliott S; Rhodes LV; Ashe HB; Wiese TE; Smith CD; Burow ME; Beckman BS
    Endocrinology; 2010 Nov; 151(11):5124-35. PubMed ID: 20861237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
    Beljanski V; Knaak C; Smith CD
    J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor.
    Guan S; Liu YY; Yan T; Zhou J
    Biochem Biophys Res Commun; 2016 Aug; 476(4):230-236. PubMed ID: 27221045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.
    French KJ; Zhuang Y; Maines LW; Gao P; Wang W; Beljanski V; Upson JJ; Green CL; Keller SN; Smith CD
    J Pharmacol Exp Ther; 2010 Apr; 333(1):129-39. PubMed ID: 20061445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
    Ren S; Xin C; Pfeilschifter J; Huwiler A
    Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus-Infected Cell Autophagic Death and Represses Tumor Growth.
    Dai L; Bai A; Smith CD; Rodriguez PC; Yu F; Qin Z
    Mol Cancer Ther; 2017 Dec; 16(12):2724-2734. PubMed ID: 28939554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.